Phase II Study of CHOP[cyclophosphamide + vincristine + doxorubicin + prednisone]/Rituxan Plus VELCADE [bortezomib] in Mediastinal Large B-Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2009
At a glance
- Drugs Bortezomib; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 06 Oct 2009 Actual number of patients (3) added as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Jun 2008 Status changed from in progress to completed.